Chemoinformatics is defined as the application of computers to develop and process chemical data. It involves the study of chemical structures using computational methods and tools. This method involves the storage and analysis of data and inferring the information. It includes the successful designing, organizing, analysis, and visualization of data which is required for pharmaceutical and biotechnology research. Chemoinformatics is being widely utilized in drug discovery & designing, information handling, screening, molecular modelling, analytical chemistry, Quantitative structure-activity relationship (QSAR) and also in polymers, food science and material science. The applications of this technique are in chemical data collection, representation, analysis, database designing, structure prediction, and building statistical model.
Based on the wide application methods we can segment the chemoinformatics market as follows:
- Drug discovery
- Virtual screening
- Drug analysis and validation
The utilization of chemoinformatics for the design of new drugs comprises of processing large data, validation of methodologies, and accessing millions of structures. The major driving factors which have driven the growth of the market includes the advancements in the drug development process and use of in-silico techniques. Chemoinformatics allows use of combinatorial chemistry to produce vast number of compounds, molecular modelling to improve drug activity; high throughput screening allowing screening of large number of compounds against a target protein, virtual in-vitro and in-silico models which replaces traditional animal testing models. As this method is able to predict toxicity and assess the risk associated with it and hence it helps in reduction of animal testing. Based on the wide scope of this technique this can be utilized in the following industries:
- Pharmaceutical companies
- Public organizations
- Academic research
- Chemical industry
Based on geography, chemoinformatics market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). At present, North America holds a leading position in the market as it observes heavy investments in R&D initiatives, technological expansions and integration of pioneering technologies, major players present in the region, and occurrence of lifestyle related diseases. Europe is followed by North America in the chemoinformatics market due to it is considered as a major hub for geriatrics. Asia Pacific is observed as a growing market due to the increasing research activities and drug development initiative in the region. Many multinational companies are setting up their business base in this region as it aids in low manufacturing and labor cost, less stringent regulations and additionally huge government initiatives which focuses on improvising R&D infrastructure for market growth.
However few factors restrict the growth of this market includes expensive chemoinformatics software and requires huge resources in terms of software and hardware. Different companies store the data in an encoded form and follow their own file formats which could be incompatible with different models. Multinational companies need to develop an international unicode for storage of data. This would enable the database to be globally accepted irrespective of type and location. This unicode will also reduce the duplication of information. Currently, there is a growing need of designing an improved chemoinformatics system which will handle the huge data which is generated from HTS operations.
It is expected that with due course of time, there will be an influx of well-established players in the chemoinformatics market. Some of the key companies operating in the chemoinformatics market are Agilent Technologies, Accelrys Software Inc., OpenEye Scientific, BIOVIA, Bio-Rad Laboratories, Inc. PerkinElmer Inc., Schrödinger, LLC, Chemical Computing Group, Inc., Certara, L.P., The Cambridge Crystallographic Data Centre (CCDC), KNIME.COM AG, EPAM Systems, Scilligence Cambridge Soft ACX, Simulations Plus, Inc., Advanced Chemistry Development, Inc. (ACD/Labs) and ChemAxon, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.